To read the full story, subscribe or sign in.

Solana Therapeutics Taps LJPC Shell to Give GCS-100 New Life

Jan. 31, 2012

La Jolla Pharmaceutical Co. is anything but new – founded in 1989, the biotech is best known for its rollercoaster ride with lupus drug Riquent (abetimus sodium).

BioWorld

NIH changes set industry up for workforce, ideas drought

BioWorld

On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...

Today's news in brief

BioWorld

BioWorld briefs for March 13, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for March 13, 2025

At CROI, HIV cure trials raise hopes for broader applicability

BioWorld

At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...

Hummingbird migrates ADCs, tech to newco Callio’s $187M debut

BioWorld

Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...